HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perry Ellis sale

This article was originally published in The Rose Sheet

Executive Summary

Parlux Fragrances has signed a letter of intent to sell its Perry Ellis fragrance rights to Victory International for $140 mil., company announces Aug. 16. Under terms of the deal, Victory will pay $120 mil. for fragrance rights and $20 mil. for inventory. The letter of intent is subject to the execution of a definitive agreement. Parlux notes the sale is appropriate due to its plans to develop other celebrity fragrance brands. The firm adds that Victory, which has handled distribution for its Fred Hayman Beverly Hills product lines, is the right partner to continue the success of the brand. Victory, which holds the license for the Carlos Santana fragrances, among others, maintains the addition of Perry Ellis will strengthen its portfolio. Parlux recently confirmed it was reviewing offers for certain brands (1"The Rose Sheet" July 24, 2006, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014158

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel